International Myeloma Foundation (IMF)   Report issue

Foundation Phase 2 Phase 3
Founded: North Hollywood CA United States (1990)

Organization Overview

First Clinical Trial
2017
NCT03143049
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

International Myeloma Foundation/Black Swan Research Initiative